Search

Search Constraints

You searched for: Author/Creator Liu, Stanley

Search Results

1. PD‐L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy. Issue 2 (8th December 2016)

4. 167 The New Diabetes Drug Canagliflozin Enhances the Response of Prostate Cancer to Radiotherapy. (October 2019)

7. Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy. (May 2020)

8. Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy. Issue 1 (January 2017)

10. 48: Intermittent Androgen Deprivation Therapy Plus Comprehensive Stereotactic Radiotherapy for Oligometastatic Prostate Cancer (CROP). (October 2021)